Power Wheelchair Group 3 denied as non-formulary by Humana?

Humana's specific coverage criteria for power wheelchair group3 are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies Group 3 Power Wheelchairs as Non-Formulary — and What That Really Means

Applying a "non-formulary" denial to durable medical equipment is less intuitive than the same denial for a prescription drug, but it does occur. For DME, Humana's equivalent mechanism is a coverage-category or preferred-supplier limitation: the specific Group 3 device model or feature configuration requested may fall outside Humana's covered DME list, or the ordering supplier may not be in Humana's preferred DME network. In either case, the member ends up with a denial that effectively functions like a non-formulary drug rejection.

## Why This Denial Is Appealable

Non-formulary or non-covered-category DME denials are challengeable on two tracks. First, if a covered equivalent is not clinically appropriate — because Group 3 features required for your specific diagnosis are only available in the requested configuration — the denial fails on medical-necessity grounds even if the category exclusion is technically accurate. Second, network-supplier limitations may have exceptions for members who cannot access a covered supplier able to provide the required device. Both tracks are worth pursuing simultaneously.

## Federal Appeal Framework

• Internal appeal: File within the EOB deadline. For pre-service standard appeals: 30 days. Expedited: 72 hours.
• External review (ACA §2719): If Humana denies internally, file for external review within approximately four months. External reviewers assess whether the denial is consistent with generally accepted clinical standards — a pure formulary exclusion that has no clinically appropriate alternative within the covered list is vulnerable at this stage.
• ERISA §503: Employer-plan members can demand the complete claim file and all plan documents. Review the Summary Plan Description and the DME benefit language carefully — non-formulary exclusions sometimes have exception processes that plan documents do not prominently advertise.

## Documentation to Gather

• Covered-alternative analysis: Request from Humana a list of covered Group 3 devices or configurations. Have your clinician and equipment supplier document in writing why each covered alternative is clinically inadequate for your specific needs.
• Supplier network documentation: If the denial involves a network-supplier issue, document that no in-network supplier can provide the clinically required device configuration.
• Prescriber exception letter: A letter from your physician specifically requesting a non-formulary/non-preferred exception, citing the clinical reason no covered alternative will meet your needs.
• Humana's DME coverage policy and formulary: Obtain both, and confirm whether there is a stated exception process for clinical necessity.

## Criteria-Mapping Structure

Build your appeal around the absence of a clinically appropriate alternative rather than the device selection itself. For each feature of the requested Group 3 device that is clinically required for your diagnosis, document: (1) the clinical need in the chart, (2) the absence of that feature in covered alternatives, and (3) the prescriber's attestation of necessity. This reframes a non-formulary denial into a medical-necessity argument — the stronger legal and clinical ground.